WallStreetZenWallStreetZen

NASDAQ: OABI
Omniab Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for OABI

Based on 1 analyst offering 12 month price targets for Omniab Inc

Min Forecast
$3.00+50%
Avg Forecast
$3.00+50%
Max Forecast
$3.00+50%

Should I buy or sell OABI stock?

Based on 1 analyst offering ratings for Omniab Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although OABI's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates OABI as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their OABI stock forecasts and price targets.

OABI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-07

1 of 1

Forecast return on equity

Is OABI forecast to generate an efficient return?

Company
-11.11%
Industry
255.07%
Market
226.45%
OABI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OABI forecast to generate an efficient return on assets?

Company
-9.96%
Industry
91.01%
OABI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OABI earnings per share forecast

What is OABI's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
-$0.55
Avg 2 year Forecast
-$0.40
Avg 3 year Forecast
-$0.31

OABI revenue forecast

What is OABI's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$19.6M-6.9%
Avg 2 year Forecast
$32.6M+54.72%
Avg 3 year Forecast
$45.9M+117.45%
OABI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OABI revenue growth forecast

How is OABI forecast to perform vs Biotechnology companies and vs the US market?

Company
29.52%
Industry
102.3%
Market
25.86%
OABI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OABI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OABI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
OABI$2.00$3.00+50.00%Buy
ALDX$4.79$9.00+87.89%Strong Buy
PBYI$5.59N/AN/A
ACIU$2.79$8.00+186.74%Strong Buy
SLN$6.26$61.67+885.10%Strong Buy
View Top Biotech Stocks

Omniab Stock Forecast FAQ

Is Omniab Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: OABI) stock is to Buy OABI stock.

Out of 1 analyst, 0 (0%) are recommending OABI as a Strong Buy, 1 (100%) are recommending OABI as a Buy, 0 (0%) are recommending OABI as a Hold, 0 (0%) are recommending OABI as a Sell, and 0 (0%) are recommending OABI as a Strong Sell.

If you're new to stock investing, here's how to buy Omniab stock.

What is OABI's earnings growth forecast for 2025-2027?

(NASDAQ: OABI) Omniab's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 44.08%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.53%.

Omniab's earnings in 2025 is -$63,668,000.On average, 9 Wall Street analysts forecast OABI's earnings for 2025 to be -$79,708,105, with the lowest OABI earnings forecast at -$81,824,249, and the highest OABI earnings forecast at -$75,576,585. On average, 8 Wall Street analysts forecast OABI's earnings for 2026 to be -$57,999,631, with the lowest OABI earnings forecast at -$74,770,435, and the highest OABI earnings forecast at -$42,322,888.

In 2027, OABI is forecast to generate -$44,928,480 in earnings, with the lowest earnings forecast at -$63,484,331 and the highest earnings forecast at -$21,161,444.

What is OABI's revenue growth forecast for 2025-2027?

(NASDAQ: OABI) Omniab's forecast annual revenue growth rate of 29.52% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 102.3%, and while it is forecast to beat the US market's average forecast revenue growth rate of 25.86%.

Omniab's revenue in 2025 is $21,094,000.On average, 9 Wall Street analysts forecast OABI's revenue for 2025 to be $2,826,996,145, with the lowest OABI revenue forecast at $2,380,158,584, and the highest OABI revenue forecast at $3,249,793,155. On average, 8 Wall Street analysts forecast OABI's revenue for 2026 to be $4,698,128,434, with the lowest OABI revenue forecast at $3,258,862,345, and the highest OABI revenue forecast at $6,801,892,650.

In 2027, OABI is forecast to generate $6,602,946,287 in revenue, with the lowest revenue forecast at $4,077,104,839 and the highest revenue forecast at $11,610,578,832.

What is OABI's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: OABI) forecast ROA is -9.96%, which is lower than the forecast US Biotechnology industry average of 91.01%.

What is OABI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year OABI price target, the average OABI price target is $3.00, with the highest OABI stock price forecast at $3.00 and the lowest OABI stock price forecast at $3.00.

The Wall Street analyst predicted that Omniab's share price could reach $3.00 by Aug 7, 2026. The average Omniab stock price prediction forecasts a potential upside of 50% from the current OABI share price of $2.00.

What is OABI's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: OABI) Omniab's current Earnings Per Share (EPS) is -$0.59. On average, analysts forecast that OABI's EPS will be -$0.55 for 2025, with the lowest EPS forecast at -$0.57, and the highest EPS forecast at -$0.53. On average, analysts forecast that OABI's EPS will be -$0.40 for 2026, with the lowest EPS forecast at -$0.52, and the highest EPS forecast at -$0.29. In 2027, OABI's EPS is forecast to hit -$0.31 (min: -$0.44, max: -$0.15).

What is OABI's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: OABI) forecast ROE is -11.11%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.